Abstract. Background:. Various prediction tools have been developed to predict biochemical recurrence (BCR) after radical prostatectomy (RP); however, few of the previous prediction tools used serum prostate-specific antigen (PSA) nadir after RP and maximum tumor diameter (MTD) at the same time. In this study, a nomogram incorporating MTD and PSA nadir was developed to predict BCR-free survival (BCRFS). Methods:. A total of 337 patients who underwent RP between January 2010 and March 2017 were retrospectively enrolled in this study. The maximum diameter of the index lesion was measured on magnetic resonance imaging (MRI). Cox regression analysis was performed to evaluate independent predictors of BCR. A nomogram was subsequently developed f...
Objective: The main objective of this study was to evaluate the factors predicting recurrence in pat...
PURPOSE: To develop a novel application evaluating the effect of tumor volume (TV) and percentage of...
An existing preoperative nomogram predicts the probability of prostate cancer recurrence, defi ned b...
Various prediction tools have been developed to predict biochemical recurrence (BCR) after radical p...
BACKGROUND. Men who undergo radical prostatectomy (RP) are at long-term risk of biochemical recurren...
BackgroundWe developed and validated an integrated radiomic-clinicopathologic nomogram (RadClip) for...
Introduction: To develop and externally validate a novel nomogram aimed at predicting cancer-specifi...
Purpose—To compare the predictive accuracy of existing models in estimating risk of biochemical recu...
Although the incidence of prostate cancer (PCa) is rapidly increasing in Korea, there are few suitab...
OBJECTIVE: To develop a preoperative nomogram to predict pathologic outcome in patients submitted to...
OBJECTIVES: Although the incidence of prostate cancer (PCa) is rapidly increasing in Korea, there ar...
<p>Panel (A) represents pre-operative nomogram and panel (B) shows post-operative nomogram.</p
OBJECTIVES: To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2...
Objective: To develop and internally validate a nomogram predicting the individual probability of me...
The most common treatment of prostate cancer (CaP) is via radical prostatectomy (RP), of which 75,00...
Objective: The main objective of this study was to evaluate the factors predicting recurrence in pat...
PURPOSE: To develop a novel application evaluating the effect of tumor volume (TV) and percentage of...
An existing preoperative nomogram predicts the probability of prostate cancer recurrence, defi ned b...
Various prediction tools have been developed to predict biochemical recurrence (BCR) after radical p...
BACKGROUND. Men who undergo radical prostatectomy (RP) are at long-term risk of biochemical recurren...
BackgroundWe developed and validated an integrated radiomic-clinicopathologic nomogram (RadClip) for...
Introduction: To develop and externally validate a novel nomogram aimed at predicting cancer-specifi...
Purpose—To compare the predictive accuracy of existing models in estimating risk of biochemical recu...
Although the incidence of prostate cancer (PCa) is rapidly increasing in Korea, there are few suitab...
OBJECTIVE: To develop a preoperative nomogram to predict pathologic outcome in patients submitted to...
OBJECTIVES: Although the incidence of prostate cancer (PCa) is rapidly increasing in Korea, there ar...
<p>Panel (A) represents pre-operative nomogram and panel (B) shows post-operative nomogram.</p
OBJECTIVES: To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2...
Objective: To develop and internally validate a nomogram predicting the individual probability of me...
The most common treatment of prostate cancer (CaP) is via radical prostatectomy (RP), of which 75,00...
Objective: The main objective of this study was to evaluate the factors predicting recurrence in pat...
PURPOSE: To develop a novel application evaluating the effect of tumor volume (TV) and percentage of...
An existing preoperative nomogram predicts the probability of prostate cancer recurrence, defi ned b...